Navigation Links
Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
Date:8/11/2009

l stem cells collected from women across mainland China, the company expects to offer other products and services associated with stem cell therapy; gene testing and disease diagnosis (i.e. gene chips; high throughput sequencings and standard molecular technologies). SEB expects to receive funding from private agencies and the government for stem cell research.

In recent years, China has significantly increased its efforts in the field of stem cell research and practice. Currently, scientific research in the country primarily utilizes bone marrow and embryonic stem cells. Clinical applications of stem cells to treat conditions such as acute heart failure, acute liver failure and lower limb ischemia have been reported by many hospitals. A developing country with the largest population in the world, China's estimated total population is 1.3 billion of which women account for about half. SEB believes that the future market opportunity for the C'elle service in China is potentially significant.

"Stem cell research and development is well-recognized and fast-emerging in China. SEB believes that the innovative proprietary technology of C'elle may provide women with the novel opportunity to collect and cryopreserve their own stem cells that have demonstrated considerable potential to be used in future therapies and are easily harvest from a non-controversial source," stated Dr. Charlie Xiang, CEO of S-Evans Biosciences. "Through SEB's expansive educational, scientific and medical affiliations, we anticipate that there may possibly be enormous potential opportunity to successfully market the compelling and highly differentiated quality service of C'elle. We are also eager to explore prospective opportunities with Cryo-Cell to collaborate on research and development of future potential stem cell therapies that may utilize this breakthrough technology."

"We are particularly interested in supporting research on stem c
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cryo-Cell International, Inc. Reports First Quarter 2009 Results
2. Cryo-Cell Renews Upromise Industry-Exclusive Agreement
3. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
4. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
5. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
6. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
7. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
8. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
9. WuXi PharmaTech Announces Second-Quarter 2009 Results
10. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
11. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 China Cord Blood Corporation ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... a Hong Kong listed company ... into an agreement (the "Agreement") to purchase the Company,s ...
(Date:5/4/2015)... , May 4, 2015   Tocagen ... updated interim data from Tocagen,s ongoing investigational studies ... Symposium of the American Association of Neurological Surgeons ... held May 1-2, 2015, in Washington, ... company held a meeting with FDA and continues ...
(Date:5/4/2015)... 4, 2015   Sentrian ™, the Remote Patient ... with the Scripps Translational Science Institute (STSI) ... patients with chronic obstructive pulmonary disease (COPD), a chronic ... the nation,s third leading cause of death. The patients ... System , a wholly owned subsidiary of Anthem.   ...
(Date:5/1/2015)... Md. , May 1, 2015  Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... the $28.5 million second tranche of a $40 million ... Woodford first invested $25 million in NW ... Woodford entered into an agreement with the Company for ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 2China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... for the brand name Ranexa(R) (ranolazine)., On July ... granted,marketing authorization for ranolazine in all 27 European Union ... approval for the Ranexa brand name in Europe provides,important ...
... Named as CEO ... COO, ALTAMONTE SPRINGS, Fla., Aug. 14 Milestone ... and commercialization of niche oncology products, today,announced the appointment ... 12, 2008. Current President, CEO and Co-founder, Frank,Jacobucci, will ...
... Bio-,Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a ... raw materials,for use in pharmaceutical, nutraceutical and food ... for the three and six month periods,ended June ... 2008, sales of our products increased,substantially. Revenue received ...
Cached Biology Technology:CV Therapeutics Receives European Approval for the Brand Name Ranexa(R) 2Milestone Biosciences, LLC Further Strengthens Executive Management Team 2Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008 2
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/30/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has ... Market in Automotive Sector 2014-2018" report to their ... Recognition market in Automotive Sector to grow at a ... Gesture recognition is the ability of a device to ... Gesture recognition technology can be 2D-based or 3D-based. It ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... Dr. Sarit Larisch, Head of the Cell Death Research Laboratory ... awarded the prestigious Johnson & Johnson Focused Funding grant for ... Parkinson,s disease. The award, which is granted each year to ... announced in 2008, and officially conferred earlier this month at ...
... thousands of years it has been prescribed by traditional healers in ... pain to fever and flu. , Now for the first time, ... pain relieving properties of Hyptis crenata otherwise known ... mice, the team led by researcher Graciela Rocha was able to ...
... The atomic-level action of a remarkable class of ... the Lawrence Berkeley National Laboratory (Berkeley Lab) using a ... (ALS). These protein motors play pivotal roles in gene ... of all biological cells, as well as infectious agents, ...
Cached Biology News:Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4
Rabbit Anti-Ferret Whole Serum Antibody, Unconjugated...
... Molecular Imaging's proprietary Focus™ detector technology, while ... the R4. The microPET Focus 120 ... avaiable PET scanner. Focus scanners also ... scinitallor based PETsystems. The combination of ...
... pAcGHLT-A,B,C ... Vector Set,pAcGHLT-XylE ... Vector,Thrombin Powder,Thrombin ... Inhibitor Cocktail,Insect ...
... has been developed to significantly increase the ... Stability is increased at room temperature ... This product is subjected to 0.45 ... azide. This formulation insures consistently high ...
Biology Products: